<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2020-04-07" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2020-04-07</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.067</td>
<td align="right">0.154</td>
<td align="right">0.000</td>
<td align="right">0.022</td>
<td align="right">0.674</td>
<td align="right">0.923</td>
<td align="right">0.030</td>
<td align="right">0.047</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.098</td>
<td align="right">0.167</td>
<td align="right">0.001</td>
<td align="right">0.050</td>
<td align="right">0.774</td>
<td align="right">0.883</td>
<td align="right">0.057</td>
<td align="right">0.060</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.140</td>
<td align="right">0.177</td>
<td align="right">0.002</td>
<td align="right">0.091</td>
<td align="right">0.827</td>
<td align="right">0.785</td>
<td align="right">0.138</td>
<td align="right">0.077</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.096</td>
<td align="right">0.175</td>
<td align="right">0.000</td>
<td align="right">0.035</td>
<td align="right">0.755</td>
<td align="right">0.859</td>
<td align="right">0.072</td>
<td align="right">0.069</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.162</td>
<td align="right">0.222</td>
<td align="right">0.004</td>
<td align="right">0.075</td>
<td align="right">0.921</td>
<td align="right">0.734</td>
<td align="right">0.129</td>
<td align="right">0.137</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.197</td>
<td align="right">0.234</td>
<td align="right">0.008</td>
<td align="right">0.105</td>
<td align="right">0.935</td>
<td align="right">0.641</td>
<td align="right">0.186</td>
<td align="right">0.173</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.246</td>
<td align="right">0.249</td>
<td align="right">0.011</td>
<td align="right">0.152</td>
<td align="right">0.947</td>
<td align="right">0.515</td>
<td align="right">0.235</td>
<td align="right">0.250</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.145</td>
<td align="right">0.202</td>
<td align="right">0.002</td>
<td align="right">0.076</td>
<td align="right">0.898</td>
<td align="right">0.753</td>
<td align="right">0.144</td>
<td align="right">0.103</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.214</td>
<td align="right">0.245</td>
<td align="right">0.008</td>
<td align="right">0.117</td>
<td align="right">0.958</td>
<td align="right">0.600</td>
<td align="right">0.204</td>
<td align="right">0.196</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.256</td>
<td align="right">0.264</td>
<td align="right">0.009</td>
<td align="right">0.152</td>
<td align="right">0.968</td>
<td align="right">0.517</td>
<td align="right">0.217</td>
<td align="right">0.266</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.308</td>
<td align="right">0.288</td>
<td align="right">0.008</td>
<td align="right">0.205</td>
<td align="right">0.978</td>
<td align="right">0.432</td>
<td align="right">0.206</td>
<td align="right">0.363</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.208</td>
<td align="right">0.225</td>
<td align="right">0.005</td>
<td align="right">0.132</td>
<td align="right">0.948</td>
<td align="right">0.574</td>
<td align="right">0.249</td>
<td align="right">0.177</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.282</td>
<td align="right">0.271</td>
<td align="right">0.010</td>
<td align="right">0.179</td>
<td align="right">0.977</td>
<td align="right">0.461</td>
<td align="right">0.226</td>
<td align="right">0.313</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.326</td>
<td align="right">0.298</td>
<td align="right">0.008</td>
<td align="right">0.214</td>
<td align="right">0.986</td>
<td align="right">0.415</td>
<td align="right">0.197</td>
<td align="right">0.388</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.375</td>
<td align="right">0.326</td>
<td align="right">0.005</td>
<td align="right">0.276</td>
<td align="right">0.993</td>
<td align="right">0.378</td>
<td align="right">0.169</td>
<td align="right">0.453</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the modelâ€™s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.192</td>
<td align="right">0.160</td>
<td align="right">0.021</td>
<td align="right">0.143</td>
<td align="right">0.635</td>
<td align="right">0.550</td>
<td align="right">0.289</td>
<td align="right">0.162</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.263</td>
<td align="right">0.197</td>
<td align="right">0.030</td>
<td align="right">0.208</td>
<td align="right">0.784</td>
<td align="right">0.375</td>
<td align="right">0.332</td>
<td align="right">0.293</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.441</td>
<td align="right">0.258</td>
<td align="right">0.070</td>
<td align="right">0.397</td>
<td align="right">0.935</td>
<td align="right">0.158</td>
<td align="right">0.258</td>
<td align="right">0.583</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.521</td>
<td align="right">0.264</td>
<td align="right">0.092</td>
<td align="right">0.508</td>
<td align="right">0.970</td>
<td align="right">0.089</td>
<td align="right">0.200</td>
<td align="right">0.711</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.6-4 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
